IRON
Disc Medicine Appoints William White to its Board of Directors
Wednesday, January 13, 2021 BiopharmaWatch Research 1 min read Key Takeaway: Disc Medicine Appoints William White to its Board of Directors
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+45%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Cash runway
~48 mo
Minimal dilution risk
Lead asset
DISC-0974
Phase 2 · Inflammatory Bowel Disease (IBD)
Full Press Release Details
Disc Medicine Appoints William White to its Board of Directors.